Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine

被引：29
作者：
Bulotta, Stefania [1 ]
Celano, Marilena [1 ]
Costante, Giuseppe [1 ,2 ]
Russo, Diego [1 ]
机构：
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Campus S Venuta, I-88100 Catanzaro, Italy
[2] Inst Jules Bordet Comprehens Canc Ctr, Dept Internal Med, Endocrinol Clin, Brussels, Belgium
来源：
ENDOCRINE | 2016年 / 52卷 / 02期
关键词：
Differentiated thyroid cancer; Radioiodine; Molecular targets; Re-differentiation strategies; Nanodevices; SODIUM-IODIDE SYMPORTER; PEGYLATED UNILAMELLAR LIPOSOMES; TYROSINE KINASE INHIBITORS; CARCINOMA CELL-LINES; NIS GENE-EXPRESSION; PHASE-II TRIAL; SODIUM/IODIDE SYMPORTER; STIMULATING HORMONE; RETINOIC ACID; DOUBLE-BLIND;
D O I：
10.1007/s12020-015-0830-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Efficient treatment of radio refractory thyroid cancer is still a major challenge. The recent identification of genetic and epigenetic alterations present in almost all differentiated tumors has revealed novel molecular targets, which can hopefully be exploited to create new treatments for these tumors. This review looks briefly at some of the innovative strategies currently being investigated for the treatment the radioiodine-resistant thyroid cancers.
引用
收藏
页码：214 / 221
页数：8
相关论文
共 83 条
[1]   Integrated Genomic Characterization of Papillary Thyroid Carcinoma [J].
Agrawal, Nishant ;
Akbani, Rehan ;
Aksoy, B. Arman ;
Ally, Adrian ;
Arachchi, Harindra ;
Asa, Sylvia L. ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Baylin, Stephen B. ;
Behera, Madhusmita ;
Bernard, Brady ;
Beroukhim, Rameen ;
Bishop, Justin A. ;
Black, Aaron D. ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
Bowen, Jay ;
Bowlby, Reanne ;
Bristow, Christopher A. ;
Brookens, Robin ;
Brooks, Denise ;
Bryant, Robert ;
Buda, Elizabeth ;
Butterfield, Yaron S. N. ;
Carling, Tobias ;
Carlsen, Rebecca ;
Carter, Scott L. ;
Carty, Sally E. ;
Chan, Timothy A. ;
Chen, Amy Y. ;
Cherniack, Andrew D. ;
Cheung, Dorothy ;
Chin, Lynda ;
Cho, Juok ;
Chu, Andy ;
Chuah, Eric ;
Cibulskis, Kristian ;
Ciriello, Giovanni ;
Clarke, Amanda ;
Clayman, Gary L. ;
Cope, Leslie ;
Copland, John A. ;
Covington, Kyle ;
Danilova, Ludmila ;
Davidsen, Tanja ;
Demchok, John A. ;
DiCara, Daniel ;
Dhalla, Noreen .
CELL, 2014, 159 (03) :676-690
[2]   Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population [J].
Ahmed, Merina ;
Barbachano, Yolanda ;
Riddell, Angela ;
Hickey, Jen ;
Newbold, Katie L. ;
Viros, Amaya ;
Harrington, Kevin J. ;
Marais, Richard ;
Nutting, Christopher M. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (02) :315-322
[3]   Peroxisomal proliferator-activated receptor-γ agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells [J].
Aiello, Aurora ;
Pandini, Giuseppe ;
Frasca, Francesco ;
Conte, Enrico ;
Murabito, Antonella ;
Sacco, Antonella ;
Genua, Marco ;
Vigneri, Riccardo ;
Belfiore, Antonino .
ENDOCRINOLOGY, 2006, 147 (09) :4463-4475
[4]   Advances in thyroid cancer treatment: latest evidence and clinical potential [J].
Alonso-Gordoa, T. ;
Diez, J. J. ;
Duran, M. ;
Grande, Enrique .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2015, 7 (01) :22-38
[5]   Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas [J].
Arturi, F ;
Russo, D ;
Giuffrida, D ;
Schlumberger, M ;
Filetti, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) :623-627
[6]   Iodide symporter gene expression in human thyroid tumors [J].
Arturi, F ;
Russo, D ;
Schlumberger, M ;
du Villard, JA ;
Caillou, B ;
Vigneri, P ;
Wicker, R ;
Chiefari, E ;
Suarez, HG ;
Filetti, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2493-2496
[7]   Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors [J].
Arturi, F ;
Russo, D ;
Bidart, JM ;
Scarpelli, D ;
Schlumberger, M ;
Filetti, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (02) :129-135
[8]   The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer [J].
Banerji, Udai ;
Camidge, D. Ross ;
Verheul, Henk M. W. ;
Agarwal, Roshan ;
Sarker, Debashis ;
Kaye, Stan B. ;
Desar, Ingrid M. E. ;
Timmer-Bonte, Johanna N. H. ;
Eckhardt, S. Gail ;
Lewis, Karl D. ;
Brown, Kathryn H. ;
Cantarini, Mireille V. ;
Morris, Clive ;
George, Sarah M. A. ;
Smith, Paul D. ;
van Herpen, Carla M. L. .
CLINICAL CANCER RESEARCH, 2010, 16 (05) :1613-1623
[9]   Notch signaling in development and cancer [J].
Bolos, Victoria ;
Grego-Bessa, Joaquin ;
de la Pompa, Jose Luis .
ENDOCRINE REVIEWS, 2007, 28 (03) :339-363
[10]   CANCER Novel target to enhance radioiodine uptake in thyroid cancer [J].
Brent, Gregory A. ;
Kogai, Takahiko .
NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (09) :508-509
123456789